THYROID ASSOCIATED OPHTHALMOPATHIES
Clinical trials for THYROID ASSOCIATED OPHTHALMOPATHIES explained in plain language.
Never miss a new study
Get alerted when new THYROID ASSOCIATED OPHTHALMOPATHIES trials appear
Sign up with your email to follow new studies for THYROID ASSOCIATED OPHTHALMOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to shrink bulging eyes in thyroid disease
Disease control Recruiting nowThis study is testing whether an experimental injection called MHB018A can reduce eye bulging and inflammation in people with active, moderate-to-severe thyroid eye disease. About 108 participants will receive either the drug or a placebo injection every four weeks for six months…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHIES
Phase: PHASE3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial offers hope for bulging, painful eyes caused by thyroid disease
Disease control Recruiting nowThis study is testing a new drug called IBI311 against the standard steroid treatment for active, moderate-to-severe Thyroid Eye Disease (TAO). It will enroll 64 adults who have not yet received steroid treatment for their eye condition. The main goal is to see which treatment is…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHIES
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New drug trial aims to shrink bulging eyes, fix double vision
Disease control Recruiting nowThis study is testing an investigational drug called IBI311 in people with inactive but moderate-to-severe Thyroid Eye Disease (TAO). The goal is to see if the drug can safely reduce eye bulging (proptosis) and improve double vision. Researchers will enroll about 50 participants …
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHIES
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for bulging eyes: experimental drug targets thyroid eye disease
Disease control Recruiting nowThis study is testing whether a new drug called Tetuzumab can help people with moderate to severe Thyroid Eye Disease who didn't get enough benefit from standard steroid treatments. Researchers will give the drug to 96 participants to see if it reduces eye bulging, inflammation, …
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHIES
Phase: PHASE4 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Scientists track eye movements to understand thyroid eye disease
Knowledge-focused Recruiting nowThis study aims to understand how Thyroid-Associated Ophthalmopathy (TAO), which causes bulging eyes and limited eye movement, affects how people move their eyes and look at things. Researchers will use non-invasive eye-tracking technology to record the gaze patterns of 100 parti…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHIES
Sponsor: Shanghai Changzheng Hospital • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC